Back to top
more

Myriad Genetics (MYGN)

(Real Time Quote from BATS)

$25.24 USD

25.24
208,861

+0.31 (1.24%)

Updated May 14, 2024 12:12 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (92 out of 250)

Industry: Medical - Biomedical and Genetics

Better trading starts here.

Zacks News

Chemed Banks on Roto-Rooter Sales, Focuses on Vitas Revival

Chemed (CHE) continues to display robust performance in Roto-Rooter business on strength in core plumbing and drain cleaning service segments.

    Walgreens Boots Invests in China to Fortify Retail Pharmacy

    Walgreens Boots' (WBA) decision to buy a minority stake in Sinopharm Holding Guoda Drugstores is likely to leverage its global pharmacy expertise.

      Edwards Lifesciences Buys Harpoon Medical, Expands Portfolio

      Edwards Lifesciences (EW) expands Surgical Heart Valve Therapy segment with the buyout of Harpoon Medical.

        Hologic Banks on Molecular Diagnostics, Competition Rife

        Hologic (HOLX) gains on increasing market share and utilization of fully-automated Panther system.

          Veeva Systems (VEEV) Beats on Earnings in Q3, Updates View

          Veeva Systems (VEEV) witnesses year-over-year growth in revenues on strength in subscription and professional services in Q3.

            Here's Why You Should Invest in PetMed (PETS) Stock Now

            PetMed's (PETS) implements strategies to revitalize top line. It also offers a comprehensive portfolio.

              IDEXX Laboratories Banks on Global Prospects, CAG Strength

              IDEXX Laboratories (IDXX) rides on strength across all segments, especially CAG. Strong fundamentals buoy optimism.

                Align Technology Rides High on InvisAlign & Strategic Pacts

                Rising demand for InvisAlign products in the global teen market and the distribution agreement with Patterson Dental are major upsides for Align (ALGN).

                  The Zacks Analyst Blog Highlights: CVS Health, Aetna, PetMed Express, Align Technology and Myriad Genetics

                  The Zacks Analyst Blog Highlights: CVS Health, Aetna, PetMed Express, Align Technology and Myriad Genetics

                    Quest Diagnostics Banks on Buyouts to Expand in Diagnostic

                    Quest Diagnostics (DGX) actively pursues merger and acquisitions to solidify hold in the high-potential diagnostic information services market. Notably, Cleveland HeartLab buyout marks as the latest deal.

                      Patterson Companies-SprintRay Deal to Boost Dental Unit

                      Patterson Companies (PDCO) focuses on acquisitions to boost dental segment.

                        CVS Health's Aetna Buyout to Change Healthcare Landscape

                        Once the Aetna deal is through, CVS Health (CVS) expects to draw $750 million from near-term synergies with low to mid-single digit accretion in the second year.

                          Cooper Companies' (COO) CooperVision Buys Paragon for $80M

                          The Cooper Companies (COO) focuses on strategic acquisitions to drive inorganic growth.

                            Boston Scientific (BSX) Shares Drop on LOTUS Relaunch Delay

                            Boston Scientific (BSX) announces a delay in deadline for the commercial return of the LOTUS Edge Aortic Valve System in Europe. Following this news, share price declines.

                              BioTelemetry's (BEAT) Telcare Unit Collaborates With Onduo

                              BioTelemetry (BEAT) progresses with deals to strengthen hold in the high-potential diabetes care market.

                                ResMed (RMD) Rides on Innovation Amid Reimbursement Woes

                                ResMed (RMD) achieves strong global revenue growth for the past few quarters on the back of sales of sleep devices, respiratory care devices, mask systems and software solutions.

                                  Here's Why You Should Add Chemed (CHE) to Your Portfolio Now

                                  Chemed (CHE) continues to ride high on strength in Roto-Rooter business.

                                    Bio-Rad (BIO) at a 52-Week High: What's Driving the Stock?

                                    Bio-Rad (BIO) consistently invests in R&D for product innovation.

                                      BioTelemetry Ties Up With Apple, Grows in Cardiac Monitoring

                                      BioTelemetry (BEAT) is consistently trying to improve its position in the cardiac monitoring and diagnostic services space.

                                        Flexion's (FLXN) Zilretta Therapy to Fast Capture OA Market

                                        Flexion's (FLXN) commercial launch of Zilretta seems well-timed keeping in view how rapidly the osteoarthritis market is growing worldwide.

                                          Veeva Systems (VEEV) Grows in Digital Asset Management Space

                                          Veeva Systems' (VEEV) constant endeavors seem to boost the Veeva Vault portfolio.

                                            Genomic Health-Cleveland Diagnostics Deal to Boost Test Suite

                                            Genomic Health (GHDX) forges ahead with deals to strengthen hold in the high-potential prostate cancer therapeutics market.

                                              GNC Holdings Grapples With Margin Weakness, Stiff Competition

                                              Weak margins, declining year-over-year revenues and rising operating costs continue to pose challenges to GNC Holdings (GNC).

                                                LabCorp's Covance Business Bounces Back on Chiltern Buyout

                                                Despite a dull show for several quarters, LabCorp's (LH) Covance Drug Development reported strong growth in the third quarter, courtesy of Chiltern acquisition. However, volume woes remain.

                                                  Align Technology (ALGN) Grows on InvisAlign System Strength

                                                  Align Technology (ALGN) continues to gain from strength in the InvisAlign space.